Equity · Healthcare
KURA
Kura Oncology, Inc. · NasdaqGS
The line runs $9.22 on 15 May through $9.20 on 5 August, on a scale from $8 to $14. Days the market did not trade hold the previous close, flat.
The chart above plots the price of KURA over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 56 sessions over that window: $9.22 on 15 May 2026 through $9.20 on 5 August 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 13, 2026
KURA insider trades
KURA has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 9 December 2025.
Showing the 12 most recent of 15 open-market trades in this window. The figures above count all of them.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 13 compensation filings in this window. The figures above count all of them.
KURA reported financials
KURA reported revenue of $67.5M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$278.7M.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
KURA earnings
Reported figures & scheduled dates · SEC EDGAR filings
KURA institutional holders
1 of the 45 institutional funds we track reported a KURA position for the quarter ended 30 Jun 2026 — a combined $6.9M; the latest of those filings landed 04 Aug 2026.
Source: SEC EDGAR 13F filings
KURA fails-to-deliver
On 10 Jul 2026, 5,372 shares of KURA failed to deliver (about $65K) — the latest of 3 consecutive trading days with recorded fails.
Source: SEC fails-to-deliver (CNS) data